[1]
P. . Thisayakorn and I. . Schuermeyer, “Psychiatric Adverse Effects of Levetiracetam in Malignant Glioma Populations; a Retrospective Cohort Study”, J Health Sci Med Res, vol. 40, no. 1, pp. 27–34, Mar. 2022.